Investigating the Impact of Kratom (Mitragyna speciosa) Use Upon Male Sexual Health

References

• Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth). Addiction. 2008;103(6):1048–1050. doi:10.1111/j.1360-0443.2008.02209.x
   PubMed Web of Science ®Google Scholar
• Eastlack SC, Cornett EM, Kaye AD. Kratom-pharmacology, clinical implications, and outlook: a comprehensive review. Pain Ther. 2020;9(1):55–69. doi:10.1007/s40122-020-00151-x
   PubMed Web of Science ®Google Scholar
• Grundmann O. Patterns of Kratom use and health impact in the US-Results from an online survey. Drug Alcohol Depend. 2017;176:63–70. doi:10.1016/j.drugalcdep.2017.03.007
   PubMed Web of Science ®Google Scholar
• Covvey JR, Vogel SM, Peckham AM, Evoy KE. Prevalence and characteristics of self-reported kratom use in a representative US general population sample. J Addict Dis. 2020;38(4):506–513. doi:10.1080/10550887.2020.1788914
   PubMed Web of Science ®Google Scholar
• Kruegel AC, Gassaway MM, Kapoor A, et al. Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators. J Am Chem Soc. 2016;138(21):6754–6764. doi:10.1021/jacs.6b00360
   PubMed Web of Science ®Google Scholar
• Yamamoto LT, Horie S, Takayama H, et al. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa. Gen Pharmacol. 1999;33(1):73–81. doi:10.1016/S0306-3623(98)00265-1
   PubMedGoogle Scholar
• Matsumoto K, Horie S, Ishikawa H, et al. Antinociceptive effect of 7-hydroxymitragynine in mice: discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2004;74(17):2143–2155. doi:10.1016/j.lfs.2003.09.054
   PubMed Web of Science ®Google Scholar
• Kruegel AC, Uprety R, Grinnell SG, et al. 7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent Sci. 2019;5(6):992–1001. doi:10.1021/acscentsci.9b00141
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Horie S, Takayama H, et al. Antinociception, tolerance and withdrawal symptoms induced by 7-hydroxymitragynine, an alkaloid from the Thai medicinal herb Mitragyna speciosa. Life Sci. 2005;78(1):2–7. doi:10.1016/j.lfs.2004.10.086
   PubMed Web of Science ®Google Scholar
• Hsieh A, DiGiorgio L, Fakunle M, Sadeghi-Nejad H. Management strategies in opioid abuse and sexual dysfunction: a review of opioid-induced androgen deficiency. Sex Med Rev. 2018;6(4):618–623. doi:10.1016/j.sxmr.2018.04.003
   PubMed Web of Science ®Google Scholar
• Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer. 2004;100(4):851–858. doi:10.1002/cncr.20028
   PubMed Web of Science ®Google Scholar
• Rubinstein AL, Carpenter DM, Minkoff JR. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids. Clin J Pain. 2013;29(10):840–845. doi:10.1097/AJP.0b013e31827c7b5d
   PubMed Web of Science ®Google Scholar
• Safarinejad MR, Asgari SA, Farshi A, et al. The effects of opiate consumption on serum reproductive hormone levels, sperm parameters, seminal plasma antioxidant capacity and sperm DNA integrity. Reprod Toxicol. 2013;36:18–23. doi:10.1016/j.reprotox.2012.11.010
   PubMed Web of Science ®Google Scholar
• Martyn-St James M, Cooper K, Kaltenthaler E, et al. Tramadol for premature ejaculation: a systematic review and meta-analysis. BMC Urol. 2015;15:6. doi:10.1186/1471-2490-15-6
   PubMed Web of Science ®Google Scholar
• Ciocanel O, Power K, Eriksen A. Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews. Sex Med. 2019;7(3):251–269. doi:10.1016/j.esxm.2019.06.001
   PubMed Web of Science ®Google Scholar
• Smith KE, Lawson T. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug Alcohol Depend. 2017;180:340–348. doi:10.1016/j.drugalcdep.2017.08.034
   PubMed Web of Science ®Google Scholar
• Nicewonder JA, Buros AF, Veltri CA, Grundmann O. Distinct kratom user populations across the United States: a regional analysis based on an online survey. Hum Psychopharmacol. 2019;34(5):e2709. doi:10.1002/hup.2709
   PubMed Web of Science ®Google Scholar
• Schimmel J, Amioka E, Rockhill K, et al. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction. 2020; 116(1):176–181.
   PubMed Web of Science ®Google Scholar
• Grundmann O, Babin JK, Henningfield JE, et al. Kratom use in the United States: a diverse and complex profile. Addiction. 2020;116:202–203. doi:10.1111/add.15173
   PubMed Web of Science ®Google Scholar
• Vicknasingam B, Narayanan S, Beng GT, Mansor SM. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of Peninsular Malaysia and implications for drug substitution therapy. Int J Drug Policy. 2010;21(4):283–288. doi:10.1016/j.drugpo.2009.12.003
   PubMed Web of Science ®Google Scholar
• Ahmad K, Aziz Z. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. J Ethnopharmacol. 2012;141(1):446–450. doi:10.1016/j.jep.2012.03.009
   PubMed Web of Science ®Google Scholar
• Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. Subst Abuse Rehabil. 2019;10:23–31. doi:10.2147/SAR.S164261
   PubMed Web of Science ®Google Scholar
• Saingam D, Assanangkornchai S, Geater AF, Balthip Q. Pattern and consequences of kratom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: a qualitative study. Int J Drug Policy. 2013;24(4):351–358. doi:10.1016/j.drugpo.2012.09.004
   PubMed Web of Science ®Google Scholar
• LaBryer L, Sharma R, Chaudhari KS, Talsania M, Scofield RH. Kratom, an emerging drug of abuse, Raises prolactin and causes secondary hypogonadism: case report. J Investig Med High Impact Case Rep. 2018;6:2324709618765022. doi:10.1177/2324709618765022
   Web of Science ®Google Scholar
• Singh DGO, Murugaiyah V, Rahim AB, Balasingam V. Improved sexual functioning of long-term daily users of Mitragyna speciosa (Korth). J Herb Med. 2019;19:100293.
   Web of Science ®Google Scholar
• Symonds T, Perelman MA, Althof S, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007;52(2):565–573. doi:10.1016/j.eururo.2007.01.028
   PubMed Web of Science ®Google Scholar
• Frink MC, Hennies HH, Englberger W, Haurand M, Wilffert B. Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung. 1996;46(11):1029–1036.
   PubMed Web of Science ®Google Scholar
• Szkutnik-Fiedler D, Kus K, Balcerkiewicz M, et al. Concomitant use of tramadol and venlafaxine - evaluation of antidepressant-like activity and other behavioral effects in rats. Pharmacol Rep. 2012;64(6):1350–1358. doi:10.1016/S1734-1140(12)70932-5
   PubMed Web of Science ®Google Scholar
• Bar-Or D, Salottolo KM, Orlando A, Winkler JV, Tramadol OD. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol. 2012;61(4):736–743. doi:10.1016/j.eururo.2011.08.039
   PubMed Web of Science ®Google Scholar
• Eggleston W, Stoppacher R, Suen K, Marraffa JM, Nelson LS. Kratom Use and Toxicities in the United States. Pharmacotherapy. 2019;39(7):775–777. doi:10.1002/phar.2280
   PubMed Web of Science ®Google Scholar